CPT Code 91035: Bravo Wireless pH Monitoring Billing, 2026 Rates, and EGD Rules

Last Updated: November 13, 2026
Table of Contents
CPT Code 91035: Bravo pH Test Billing Guide (2026)

What is CPT code 91035?

CPT code 91035 is a gastroesophageal reflux test that reports wireless esophageal pH monitoring using a telemetry electrode attached to the esophageal mucosa, including placement, recording, analysis, and interpretation. It is the code for Bravo capsule studies. Medicare pays about $502.35 globally in 2026, or $85.17 for the physician’s professional component.

  • Global vs. professional billing: In a hospital or ambulatory surgery center, the gastroenterologist bills 91035 with modifier 26, and the facility bills the technical portion; the global code applies only when the practice owns the equipment and performs the study in its office.
  • Bravo placed during an EGD: Medicare’s correct coding edits bundle diagnostic EGD 43235 into 91035, so the EGD is billed separately only when it has its own documented indication and the claim carries modifier 59 or XS.
  • One unit per study: 91035 is reported once per study, whether the capsule records for 48 or 96 hours, and it cannot be billed with catheter pH or impedance codes 91034, 91037, or 91038.

CPT 91035 Description and How It Differs From 91034

The CPT descriptor for 91035 is esophagus, gastroesophageal reflux test; with mucosal attached telemetry pH electrode placement, recording, analysis and interpretation. In practice, that means a wireless capsule, most commonly the Bravo system, is attached to the esophageal lining about 6 centimeters above the squamocolumnar junction, usually during upper endoscopy, and transmits pH data to a recorder the patient wears for 48 to 96 hours.

The code includes four elements: placing the capsule, recording the data, analyzing it, and interpreting it. None of those is billed separately. The capsule itself is a supply included in the technical component, so there is no separate HCPCS supply code for it on a Medicare claim.

CPT 91034 is the catheter-based alternative. It reports a nasal catheter pH electrode with recording, analysis, and interpretation, typically for a 24-hour study. Impedance testing uses 91037 for a study of up to one hour and 91038 for prolonged studies over one hour, which in practice means 24-hour combined pH-impedance monitoring. The choice between them is clinical, but the coding consequence is strict: the October 2026 Medicare National Correct Coding Initiative edits bundle 91034, 91037, and 91038 into 91035 with a modifier indicator of 0, so a practice cannot bill wireless pH and catheter studies together on the same date.

CodeWhat it reports2026 global rate2027 global rate
91035Wireless pH capsule (Bravo), placement through interpretation$502.35$468.87
91034Catheter pH study, nasal electrode$202.41$189.57
91037Esophageal impedance, up to 1 hour$187.38$176.19
91038Esophageal impedance, prolonged (over 1 hour)$445.90$416.34
91010Esophageal motility (manometry) study$245.83$230.68

Rates are Medicare national nonfacility amounts from the CMS October 2026 relative value file at the $33.4009 conversion factor and the CY 2027 final rule, released November 4, 2026, at $32.6286. The Medically Unlikely Edit for 91035 is 1 unit per day.

One question we hear constantly from GI practice managers is whether a 96-hour Bravo study can be billed as two units because it covers four days. It cannot. The code describes the study, not the recording days, and the unit limit enforces that.

How much does CPT 91035 pay in 2026 and 2027?

Medicare’s 2026 national rate for 91035 is about $502.35 globally, $85.17 for the professional component, and $417.18 for the technical component. Under the CY 2027 final rule, those fall to about $468.87, $81.25, and $387.63. An ambulatory surgery center receives about $392.12 in 2027 when the study is performed with a covered procedure.

SettingWho bills what2026 Medicare2027 Medicare
Physician office, practice-owned equipmentPractice bills 91035 global$502.35$468.87
Hospital or ASC, physicianGastroenterologist bills 91035-26$85.17$81.25
Office, technical onlyPractice bills 91035-TC$417.18$387.63

The 2027 professional rate drops about 4.6%, and the global rate about 6.7%, driven by the 2.31% conversion factor cut and a reduction in practice expense value. The ASC figure comes from the CY 2027 OPPS and ASC final rule ancillary services file, where 91035 carries payment indicator Z3. That indicator marks a diagnostic service paid separately to the ASC when it is integral to a covered surgical procedure, such as an EGD.

The site of service changes the claim entirely. When a gastroenterologist places a Bravo capsule during an EGD at an ambulatory surgery center, the physician claim shows 91035-26 and any separately supported EGD code, while the ASC claim shows the EGD and 91035 for the facility payment. When the capsule is placed in a hospital outpatient department, the hospital bills the technical side under the outpatient prospective payment system.

Most commercial payers follow the same component structure but price it on their own fee schedules, and many require prior authorization for Bravo, particularly when ordered before antireflux surgery. Across the billing companies in our network, prior authorization gaps on reflux testing are one of the more frequent front-end issues GI groups bring up when they start looking for a new partner.

Can you bill an EGD with CPT 91035?

Yes, but only when the EGD has its own medical indication. Medicare edits bundle diagnostic EGD 43235 into 91035 with a modifier indicator of 1. If the endoscopy was performed only to place the capsule, bill 91035 alone. If it was a separately indicated diagnostic EGD, append modifier 59 or XS to 43235.

The logic follows the code descriptor. CPT 91035 includes placement of the electrode, and endoscopic guidance used only to place the capsule is part of that placement. A diagnostic EGD performed to evaluate dysphagia, Barrett’s esophagus surveillance, or alarm symptoms is a distinct service that happens to occur in the same session. Our guide to CPT 43235 diagnostic EGD billing covers the documentation that supports a standalone diagnostic endoscopy.

The October 2026 practitioner edits pair 91035 with 43235 and with 43210, transoral esophagogastric fundoplasty, both with modifier indicator 1. EGD with biopsy, 43239, is not paired with 91035 in those edits, so when the endoscopist takes biopsies, the biopsy EGD can be reported alongside the Bravo study without a bypass modifier, assuming documentation supports both.

Consider the financial stakes. Using 2027 Medicare national facility rates, 43235 pays the physician about $106.04 and 91035-26 about $81.25. A group performing 150 Bravo studies a year with diagnostic EGDs would bill about $15,906 in 43235 professional fees. If those EGDs were performed only for placement but billed with modifier 59, that entire amount is exposed to recoupment on audit. If they were separately indicated but the modifier was left off, the same amount is denied.

Bravo with EGD is a small claim with outsized audit risk. Compare GI billing companies in our network, with rates starting as low as 2.95%, and get connected within 30 minutes.

How to Bill CPT 91035 Correctly

  • Confirm whether the study is wireless or catheter-based, and choose 91035 only for a mucosal-attached capsule.
  • Identify the site of service and append modifier 26 when the procedure is performed in a hospital or ambulatory surgery center.
  • Document a separate indication before billing a diagnostic EGD with the Bravo study, and append modifier 59 or XS to 43235 only then.
  • Report one unit of 91035 per study, regardless of whether the recording runs 48 or 96 hours.
  • Link a supporting diagnosis, such as K21.9, K21.00, or R12, to the study line.
  • Verify prior authorization for commercial and Medicare Advantage plans before scheduling the capsule.
  • Bill the interpretation only after the recording is analyzed and the report is signed.

Diagnosis coding drives medical necessity. Common supporting codes include K21.9 for gastro-esophageal reflux disease without esophagitis, K21.00 for reflux with esophagitis without bleeding, R12 for heartburn, and R05.3 for chronic cough when an extraesophageal reflux cause is being evaluated. Pre-surgical studies should reference the documented reflux history that supports the evaluation.

The date of service is another frequent problem. The capsule is placed on one day and the interpretation is completed several days later. Because the code includes placement through interpretation, the claim should not be split across dates, and most payers expect the study to be billed once the interpretation is complete, using the date the payer’s policy specifies.

In our experience matching providers with billing partners, GI groups that build a dedicated Bravo charge template, one that asks about the EGD indication and the site of service before the claim is coded, see fewer modifier errors than groups that code the study from the endoscopy report alone.

Common CPT 91035 Denials

The first common denial is billing 91035 with 91034, 91037, or 91038. Those catheter and impedance codes bundle into the wireless study with a modifier indicator of 0, so no modifier will unlock them. If both types of testing truly occurred on different days, each date stands on its own.

The second is billing global 91035 from a hospital or ASC. A gastroenterologist who places the capsule at a facility does not own the equipment or perform the technical recording, so the professional claim needs modifier 26. Billing the global code from a facility setting invites a recoupment for the technical portion.

The third is the EGD bundle. Claims with 43235 and 91035 and no bypass modifier deny the EGD, while claims with modifier 59 and no separate indication in the record fail on audit. The fix is documentation, not modifiers: the endoscopy report should state why the EGD was needed beyond placing the capsule.

The fourth is missing prior authorization. Many commercial plans and Medicare Advantage plans manage reflux testing, especially before surgery, and a study performed without approval is often unrecoverable. For broader 2027 coding changes affecting GI procedure revenue, including new endoscopic submucosal dissection codes, see our coverage of 2027 ESD CPT codes.

Providers often come to us after a payer audit flagged a pattern of 43235 billed with modifier 59 alongside every Bravo study. In nearly every case, the clinical work was legitimate, but the reports did not record the separate indication, which is why the audit succeeded.

Frequently Asked Questions

What is the difference between 91034 and 91035?

CPT 91034 reports a catheter-based pH study using a nasal electrode, usually for 24 hours. CPT 91035 reports wireless pH monitoring with a capsule attached to the esophageal mucosa, such as Bravo, usually for 48 to 96 hours. The two cannot be billed together on the same date under Medicare edits.

Does 91035 include the EGD?

It includes endoscopic guidance used only to place the capsule. Medicare edits bundle diagnostic EGD 43235 into 91035, so a separately indicated diagnostic EGD needs modifier 59 or XS and supporting documentation. EGD with biopsy, 43239, is not bundled with 91035 under the October 2026 edits.

Should 91035 be billed with modifier 26?

Yes, when the capsule is placed in a hospital or ambulatory surgery center. The physician bills 91035-26 for the professional component, about $85.17 nationally in 2026. The global code is billed only when the practice owns the recording equipment and performs the full study in its office.

Can 91035 be billed for each recording day?

No. CPT 91035 is reported once per study, whether the wireless capsule records for 48 hours or for the full 96 hours. Medicare’s Medically Unlikely Edit allows 1 unit per day, and the descriptor covers placement, recording, analysis, and interpretation as a single service.

What ICD-10 codes support 91035?

Common supporting codes include K21.9 for reflux disease without esophagitis, K21.00 for reflux with esophagitis without bleeding, R12 for heartburn, and R05.3 for chronic cough when reflux is suspected. The diagnosis should match the documented reason for testing, such as symptoms refractory to treatment or pre-surgical evaluation.

Does an ASC get paid for 91035?

Yes, when the study is integral to a covered surgical procedure such as an EGD. In the CY 2027 OPPS and ASC final rule, 91035 carries ASC payment indicator Z3 with a national payment of about $392.12. The physician bills the professional component separately with modifier 26.

Next Steps

CPT 91035 pays well for a single study, but the claim depends on getting the site of service, the EGD relationship, and the unit count right. Start with a 90-day review of every Bravo claim: confirm modifier 26 appears on every facility-based study, check that every 43235 billed alongside 91035 has a separate indication in the report, and confirm no catheter or impedance codes were billed on the same date.

Then compare your 2026 collections against the 2027 rates, since the professional component falls about 4.6% in January. Our guides to CPT 43235 and CPT 91200 liver elastography cover two other GI codes with the same professional and technical split, and our 2027 ESD coding coverage explains the newest endoscopic codes. If your team does not have time to audit Bravo claims and keep prior authorizations current, a billing company that specializes in gastroenterology can take that on and report denial trends back to you each month.

Finally, share the Bravo coding rules with your endoscopy schedulers and ASC staff. When the people booking the procedure know whether an EGD is planned for its own indication, whether prior authorization is needed, and which setting the study will occur in, the claim is built correctly before the capsule is ever placed.

Get matched with a GI billing company that knows Bravo, EGD bundling, and ASC billing rules. Rates start as low as 2.95%, and the match is free.

Get Matched In 30 Minutes

Get a FREE Quote

Tell us about your practice and we'll connect you with trusted billing companies.

100% Free to providers — No hidden fees at any stage

Tim Daniels
Online now
Tim Daniels

How can I help?

Send me your number and I'll personally call you in less than 24 hours to discuss any questions you may have about our gastroenterology billing partners

Mon–Fri, 9:00am–5:30pm Or email instead →
Got it — talk soon.
I'll call you within one business hour. Check your phone for an unknown number.